FX-909

· Flare Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FX-909, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma [Phase 1]